Spruce Biosciences
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $602 | $1,610 | $2,001 | $2,887 |
Gross Profit | 602 | -6,480 | 1,986 | 2,871 |
EBITDA | -8,590 | -9,086 | -11,513 | -9,828 |
EBIT | -8,600 | -9,098 | -11,528 | -9,844 |
Net Income | -8,671 | -9,181 | -11,625 | -9,950 |
Net Change In Cash | 602 | 1,610 | 2,001 | 2,887 |
Free Cash Flow | -9,223 | -11,106 | -14,958 | -11,209 |
Cash | 60,055 | 69,683 | 81,154 | 96,339 |
Basic Shares | 41,302 | 41,163 | 41,096 | 41,029 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $10,089 | $1,964 | $0 | $0 |
Gross Profit | -39,343 | -429 | -381 | -102 |
EBITDA | -47,366 | -45,331 | -41,566 | -29,114 |
EBIT | -47,436 | -45,760 | -41,947 | -29,216 |
Net Income | -47,919 | -45,077 | -42,688 | -30,026 |
Net Change In Cash | 10,089 | 1,964 | 0 | 0 |
Cost of Revenue | -18,232 | 153,442 | ||
Free Cash Flow | -33,282 | -41,691 | -35,970 | -27,593 |
Cash | 96,339 | 24,487 | 42,748 | 157,150 |
Basic Shares | 38,510 | 23,527 | 23,361 | 23,260 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.21 |
2024-06-30 | -$0.22 |
2024-03-31 | -$0.28 |
2023-12-31 | -$0.24 |
